We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Sector Composition

Rank Sector Weight
1 Industrials 5.58%
2 Technology 4.55%
3 Healthcare 4.09%
4 Financials 3.79%
5 Consumer Discretionary 3.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUBG icon
2001
HUB Group
HUBG
$2.46B
$26K ﹤0.01%
1,230
+702
+133% +$14.7K
IDT icon
2002
IDT Corp
IDT
$1.63B
$26K ﹤0.01%
+2,716
New +$20K
INDP icon
2003
Indaptus Therapeutics
INDP
$141M
$26K ﹤0.01%
+3
New +$37.8K
INTU icon
2004
Intuit
INTU
$98B
$26K ﹤0.01%
98
-5,055
-98% -$1.28M
KBE icon
2005
State Street SPDR S&P Bank ETF
KBE
$1.75B
$26K ﹤0.01%
600
+454
+311% +$19.7K
LE icon
2006
Lands' End
LE
$391M
$26K ﹤0.01%
+2,164
New +$32.7K
LFVN icon
2007
LifeVantage
LFVN
$81.9M
$26K ﹤0.01%
2,061
+531
+35% +$6.31K
LGND icon
2008
Ligand Pharmaceuticals
LGND
$5.76B
$26K ﹤0.01%
365
+238
+187% +$17.5K
NMFC icon
2009
New Mountain Finance
NMFC
$728M
$26K ﹤0.01%
1,860
-13,066
-88% -$183K
NVS icon
2010
Novartis
NVS
$288B
$26K ﹤0.01%
285
-1,162
-80% -$98.3K
PBH icon
2011
Prestige Consumer Healthcare
PBH
$2.43B
$26K ﹤0.01%
826
-4,750
-85% -$141K
PFG icon
2012
Principal Financial Group
PFG
$24.4B
$26K ﹤0.01%
450
-9,890
-96% -$545K
PODD icon
2013
Insulet
PODD
$10.1B
$26K ﹤0.01%
217
-526
-71% -$53.9K
TBBK icon
2014
The Bancorp
TBBK
$2.83B
$26K ﹤0.01%
2,969
+876
+42% +$8.06K
TEF
2015
DELISTED
Telefonica
TEF
$26K ﹤0.01%
3,807
-13,271
-78% -$88.2K
TGI
2016
DELISTED
Triumph Group
TGI
$26K ﹤0.01%
1,150
-24
-2% -$516
TVTX icon
2017
Travere Therapeutics
TVTX
$5.79B
$26K ﹤0.01%
+1,309
New +$25.8K
VOT icon
2018
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$20.3B
$26K ﹤0.01%
172
+167
+3,340% +$24.4K
WGO icon
2019
Winnebago Industries
WGO
$915M
$26K ﹤0.01%
662
-18,260
-97% -$642K
NUAN
2020
DELISTED
Nuance Communications, Inc.
NUAN
$26K ﹤0.01%
+1,854
New +$27.3K
MR
2021
DELISTED
Montage Resources Corporation Common Stock
MR
$26K ﹤0.01%
+4,242
New +$42.3K
BGC icon
2022
BGC Group
BGC
$5.2B
$25K ﹤0.01%
+4,816
New +$25K
EIDO icon
2023
iShares MSCI Indonesia ETF
EIDO
$484M
$25K ﹤0.01%
963
-431
-31% -$10.9K
EQBK icon
2024
Equity Bancshares
EQBK
$1.07B
$25K ﹤0.01%
+938
New +$25K
ETON icon
2025
Eton Pharmaceutcials
ETON
$1.12B
$25K ﹤0.01%
3,139
+1,728
+122% +$13.4K

Similar funds

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.6% of assets, up from 5% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.